|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.240 USD | -4.03% |
|
-19.51% | +8.49% |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.03% | -19.51% | -20.00% | -25.14% | +8.49% | +764.26% | +84.51% | -83.19% | -37.32% | 573M | |
| -7.17% | -2.63% | +20.10% | +11.57% | +30.06% | +49.59% | +74.24% | -28.59% | - | 55.98B | |
| +0.24% | -5.62% | -0.50% | +5.83% | +4.91% | +54.73% | +125.15% | +190.35% | +5,511.94% | 53.69B | |
| +0.80% | -8.41% | +13.40% | -24.14% | -37.76% | +3.57% | +425.83% | +306.30% | +850.18% | 23.29B | |
| -0.09% | -1.61% | +2.21% | -10.42% | -3.91% | -18.68% | -15.48% | -60.48% | - | 23.15B | |
| -5.95% | -0.22% | +23.18% | -0.54% | +17.62% | +35.96% | -9.58% | -73.57% | - | 20.58B | |
| -1.14% | -3.16% | +20.12% | +4.41% | -7.79% | +32.88% | -28.80% | -31.46% | +63.66% | 17.76B | |
| -5.16% | -7.00% | +33.76% | +100.85% | +182.04% | +177.56% | +326.39% | +1,565.96% | +592.91% | 16.09B | |
| -6.91% | +2.40% | +14.34% | -6.82% | +24.02% | +36.86% | +636.97% | - | - | 15.93B | |
| +0.43% | -2.07% | +7.33% | +26.00% | +27.58% | +24.79% | +188.40% | +232.86% | +562.56% | 14B | |
| +1.46% | -1.17% | +10.43% | +5.47% | -4.96% | +60.44% | +145.15% | +489.62% | - | 12.58B | |
| -13.21% | -6.66% | +4.37% | -40.70% | -21.81% | -29.88% | +138.14% | +52.20% | - | 11.96B | |
| +0.36% | -10.79% | -0.50% | -43.45% | -21.04% | -51.15% | +545.33% | +95.06% | +82.92% | 10.68B | |
| -0.22% | -6.84% | +6.61% | +22.56% | +26.19% | +107.29% | +129.54% | +316.95% | +710.72% | 10.91B | |
| +4.10% | -11.55% | -2.94% | +9.30% | +11.91% | +306.01% | +114.74% | +17.14% | +1,178.83% | 10.05B | |
| -10.29% | -6.96% | +11.48% | -35.38% | +5.90% | +11.15% | +75.89% | -28.80% | - | 9.42B | |
| +6.49% | +1.50% | +20.17% | +43.80% | +205.95% | +518.70% | +617.21% | -40.78% | -11.30% | 8.28B | |
| -0.06% | +0.29% | +139.60% | +114.92% | +80.15% | +162.88% | +311.68% | +325.25% | - | 8.85B | |
| -7.57% | -5.71% | +36.96% | +15.50% | +10.13% | +17.02% | +299.37% | +270.00% | - | 8.24B | |
| +0.29% | -6.07% | +13.97% | -9.65% | +21.80% | +53.68% | +13.22% | +161.40% | - | 8.09B | |
| Average | -2.38% | -2.58% | +17.70% | +8.20% | +27.97% | +115.88% | +209.89% | +193.48% | +950.51% | 17.01B | |
| Weighted average by Cap. | -2.66% | -2.61% | +15.60% | +7.77% | +22.02% | +63.02% | +178.87% | +178.66% | +2,145.28% |
- Stock Market
- Stocks
- RLMD Stock
- Sector Relmada Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
